Most Recent

image: Thomas Gregor: Biological Quantifier

Thomas Gregor: Biological Quantifier

By | November 1, 2013

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: Megan Carey: Cerebellum Prober

Megan Carey: Cerebellum Prober

By | August 1, 2012

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Physics, Princeton University. Age: 39

3 Comments

image: Frank Bradke: Privy to Axon Growth

Frank Bradke: Privy to Axon Growth

By | December 1, 2011

Assistant Professor, Physics, Princeton University. Age: 39

5 Comments

image: Seirian Sumner: Wasp Whisperer

Seirian Sumner: Wasp Whisperer

By | August 1, 2011

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: Harmit Malik: Viral Historian

Harmit Malik: Viral Historian

By | July 1, 2011

Assistant Professor, Physics, Princeton University. Age: 39

3 Comments

image: Ted Cohen: Travelling for TB

Ted Cohen: Travelling for TB

By | March 1, 2011

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: Jeremy Reiter: Hunting for Cilia

Jeremy Reiter: Hunting for Cilia

By | January 1, 2011

Assistant Professor, Physics, Princeton University. Age: 39

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech